Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06025721 · ClinicalTrials.gov registry record · NA

Behavior Change Intervention for Cardiovascular Risk Reduction Among People Experiencing Homelessness

A NA study of Hypertension and Diabetes Mellitus, Type 2, sponsored by Katherine Vickery.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT06025721 is a NA study of Hypertension and Diabetes Mellitus, Type 2 that has completed, run by Katherine Vickery. The registered enrollment target is 9 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06025721, a NA study of Hypertension and Diabetes Mellitus, Type 2, has completed, sponsored by Katherine Vickery.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

This single-arm trial of the Cardiovascular Risk Reduction Among People Experiencing Homelessness (CV-Homes) intervention alone (n=8) will test the perception and feasibility of anticipated study procedures.

Interventions

  • BEHAVIORAL Cardiovascular Risk Homeless Support

Study Locations (1)

Minnesota

  • Hennepin Healthcare Research Institute - Minneapolis

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2024-01-05
Est. Completion 2024-10-16
Phase NA

Sponsor

Katherine Vickery

2 total trials

What the Registry Record Tells You About NCT06025721

The ClinicalTrials.gov registry entry for NCT06025721 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (100% lower). The listed sponsor is Katherine Vickery, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Cardiovascular Risk Homeless Support is the first listed.

NCT06025721 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06025721 about?

NCT06025721 is a clinical study titled "Behavior Change Intervention for Cardiovascular Risk Reduction Among People Experiencing Homelessness". This single-arm trial of the Cardiovascular Risk Reduction Among People Experiencing Homelessness (CV-Homes) intervention alone (n=8) will test the perception and feasibility of anticipated study procedures.

What is the current status of trial NCT06025721?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2024-01-05. Estimated completion is 2024-10-16.

What conditions does trial NCT06025721 study?

This clinical trial studies the following conditions: Hypertension, Diabetes Mellitus, Type 2, Heart Diseases, Pre Diabetes, Hyperlipidemias.

What interventions are being tested in trial NCT06025721?

The interventions under investigation include: Cardiovascular Risk Homeless Support (BEHAVIORAL).

Who is sponsoring clinical trial NCT06025721?

This trial is sponsored by Katherine Vickery, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06025721 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.